No abstract

We describe a multi-platform ((1)H NMR, LC-MS, microarray) investigation of metabolic disturbances associated with the leptin receptor defective (db/db) mouse model of type 2 diabetes using novel assignment methodologies. For the first time, several urinary metabolites were found to be associated with diabetes and/or diabetes progression and confirmed in both NMR and LC-MS datasets. The confirmed metabolites were trimethylamine-n-oxide (TMAO), creatine, carnitine, and phenylalanine. TMAO and phenylalanine were both elevated in db/db mice and decreased in these mice with age. Levels of both creatine and carnitine increase in diabetic mice with age and creatine was also significantly decreased in db/db mice. Additionally, many metabolic markers were found by either NMR or LC-MS, but could not be found in both, due to instrumental limitations. This indicates that the combined use of NMR and LC-MS instrumentation provides complementary information that would be otherwise unattainable. Pathway analyses of urinary metabolites and liver, muscle, and adipose tissue transcripts from the db/db model were also performed to identify altered biochemical processes in the diabetic mice. Metabolite and liver transcript levels associated with the TCA cycle and steroid processes were altered in db/db mice. In addition, gene expression in muscle and liver associated with fatty acid processing was altered in the diabetic mice and similar evidence was observed in the LC-MS data. Our findings highlight the importance of a number of processes known to be associated with diabetes and reveal tissue specific responses to the condition. When studying metabolic disorders such as diabetes, multiple platform integrated profiling of metabolite alterations in biofluids can provide important insights into the processes underlying the disease.

Assignment of physical meaning to mass spectrometry (MS) data peaks is an important scientific challenge for metabolomics investigators. Improvements in instrumental mass accuracy reduce the number of spurious database matches, however, this alone is insufficient for accurate, unique high-throughput assignment. We present a method for clustering MS instrumental artifacts and a stochastic local search algorithm for the automated assignment of large, complex MS-based metabolomic datasets. Artifact peaks and their associated source peaks are grouped into ''instrumental clusters.'' Instrumental clusters, peaks grouped together by shared peak shape in the temporal domain, serve as a guide for the number of assignments necessary to completely explain a given dataset. We refine mass only assignments through the intersection of peak correlation pairs with a database of biochemically relevant interaction pairs. Further refinement is achieved through a stochastic local search optimization algorithm that selects individual assignments for each instrumental cluster. The algorithm works by choosing the peak assignment that maximally explains the connectivity of a given cluster. We demonstrate that this methodology provides a significant advantage over standard methods for the assignment of metabolites in a UPLC-MS diabetes dataset.

No abstract

In this paper an application of the uninformative variable elimination-partial least squares (UVE-PLS) method extended by the Monte Carlo approach for selection of possible biomarkers from the liquid chromatography coupled with mass spectrometry (LC-MS) data is reported. The main challenge consists not in the chemometrics analysis of LC-MS data, but in the data organization. However, as demonstrated in our study, the selected variables are similar regardless of the data organization strategy. The best results are obtained for the standard normal variate (SNV) transformed data.